GAAP net income was $397 million, or $3.33 per share, compared to $293 million, or $2.45 per share, in the prior-year quarter. Adjusted net income totaled $409 million, or $3.43 per share, topping forecasts of $2.99 per share.
During the quarter, worldwide da Vinci procedures grew nearly 20% versus last year, driven mainly by growth in US general surgery procedures and worldwide urologic procedures. Intuitive shipped 275 da Vinci Surgical Systems, which was up 19% from the prior-year period, and grew its da Vinci Surgical System installed base to 5,406 systems as of quarter-end, reflecting a year-over-year increase of 12%.
Also read: Intuitive Surgical Q3 2019 Earnings Preview
Instrument and accessory revenue increased 25% year-over-year to $606 million, mainly driven by a growth in da Vinci procedure volume. Systems revenue rose by 23% to $339 million.
Intuitive ended the third quarter with $5.4 billion in cash, cash equivalents, and investments.
In August, the company acquired Scholly Fiberoptic’s robotic endoscope business, which is expected to strengthen the supply chain and increase manufacturing capacity for imaging products.
Get access to timely and accurate verbatim transcripts that are published within hours of the event.